With a distinguished background in entrepreneurship and advocacy, Paul Elam has carved out a niche in the discourse surrounding men's issues. As the founder of A Voice for Men, he leads initiatives focused on raising awareness about men's rights and related social challenges. His efforts have positioned him as a significant figure within discussions around gender equality and activism, allowing him to engage diverse audiences through lectures and media appearances. Through his leadership, Elam amplifies critical dialogues that impact various sectors including education, healthcare, and legal reforms related to masculinity.
With a distinguished background in entrepreneurship and advocacy, Paul Elam has carved out a niche in the discourse surrounding men's issues. As the founder of A Voice for Men, he leads initiatives focused on raising awareness about men's rights and related social challenges. His efforts have positioned him as a significant figure within discussions around gender equality and activism, allowing him to engage diverse audiences through lectures and media appearances. Through his leadership, Elam amplifies critical dialogues that impact various sectors including education, healthcare, and legal reforms related to masculinity.
With a profound understanding of societal dynamics, Paul Elam pursues investment opportunities that challenge conventional narratives and seek social change. His entrepreneurial mindset drives a focus on ventures that elevate men's issues, fostering innovation within advocacy-oriented businesses. Leveraging his leadership experience, he identifies potential in organizations committed to enhancing men’s health and rights. This strategic approach not only highlights gaps in current market offerings but also emphasizes building awareness as a value proposition, blending impact investing with personal values.
With a profound understanding of societal dynamics, Paul Elam pursues investment opportunities that challenge conventional narratives and seek social change. His entrepreneurial mindset drives a focus on ventures that elevate men's issues, fostering innovation within advocacy-oriented businesses. Leveraging his leadership experience, he identifies potential in organizations committed to enhancing men’s health and rights. This strategic approach not only highlights gaps in current market offerings but also emphasizes building awareness as a value proposition, blending impact investing with personal values.
| Trades 3122 | Longs Won 1930/3122 61% | Profit Factor 2.97 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $365,355.95 |
| Average Win $80,154.53 | Best Trade (Jun 30) $9.03M | Sharpe Ratio -9.32 |
| Average Loss -$43,669.69 | Worst Trade (Mar 31) -$8.97M | Z-Score 9.73 (100%) |
| Commissions $0 | Avg. Trade Length 2y 3w 6d | Expectancy $32,877.63 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 6,250 | 5,625 | 5,000 | 4,375 | 3,750 | 3,125 | 2,500 | 1,875 | 1,250 | 625 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 48,190 | $8.5M | $15.06M | - | $6.56M | 77.13% | +0.453% |
ABBV AbbVie Inc. | 3,945 | $548,634.75 | $961,791 | - | $413,156.25 | 75.31% | -0.975% |
ABT Abbott Laboratories | 28,775 | $4M | $3.03M | - | -$967,913.98 | -24.18% | -0.236% |
ACWI iShares MSCI ACWI ETF | 3,000 | $317,340 | $480,345 | - | $163,005 | 51.37% | -0.24% |
ACWX ISHARES MSCI ACWI EX U.S. ETF | 1,000 | $55,600 | $76,640 | - | $21,040 | 37.84% | -0.364% |
AGG iShares Core U.S. Aggregate Bond ETF | 29,444 | $2.92M | $2.88M | - | -$42,568.15 | -1.46% | 0.0 |
AMD Advanced Micro Devices, Inc. | 514 | $298,587.72 | $253,237.52 | - | -$45,350.2 | -15.19% | +2.205% |
AMGN Amgen Inc. | 1,575 | $453,878.73 | $614,281.48 | - | $160,402.75 | 35.34% | -4.367% |
AMZN Amazon.com Inc | 17,406 | $2.71M | $4.74M | - | $2.03M | 74.9% | -0.143% |
ASH Ashland Inc. | 4,062 | $210,873.1 | $293,763.84 | - | $82,890.74 | 39.31% | +0.865% |
AVDE Avantis International Equity ETF | 2,280 | $206,682 | $211,971.6 | - | $5,289.6 | 2.56% | 0.0 |
AVEM Avantis Emerging Markets Equity ETF | 100 | $9,649 | $9,218 | - | -$431 | -4.47% | 0.0 |
AVGO Broadcom Inc. | 2,013 | $295,598.87 | $854,961.36 | - | $559,362.49 | 189.23% | +1.54% |
AVLV Avantis U.S. Large Cap Value ETF | 4,188 | $381,987.48 | $385,966.08 | - | $3,978.6 | 1.04% | -1.517% |
BAC Bank of America Corporation | 8,909 | $362,792.92 | $563,494.25 | - | $200,701.33 | 55.32% | 0.0 |
BBHY JPMorgan BetaBuilders U.S. High Yield Fund | 344 | $15,872.32 | $15,729.4 | - | -$142.92 | -0.9% | +0.033% |
BBUS JPMorgan Betabuilders U.S. Equity Fund | 2,427 | $297,826.62 | $326,674.22 | - | $28,847.6 | 9.69% | -3.005% |
BDJ BlackRock Enhanced Equity Dividend Trust | 21,139 | $213,081.12 | $207,373.59 | - | -$5,707.53 | -2.68% | 0.0 |
BLK BlackRock, Inc. | 247 | $273,634.56 | $278,327.01 | - | $4,692.45 | 1.71% | -0.595% |
BND Vanguard Total Bond Market Index Fund | 50,725 | $3.77M | $3.66M | - | -$102,198.32 | -2.71% | -0.317% |